A critical advance in cancer research is occurring with the use of mini-antibodies to reactivate mutated p53. This crucial malignant inhibitor protein is frequently disabled in many types of cancer, resulting https://mysocialfeeder.com/story6881083/nanobodies-restore-tumor-suppressor-p53-a-promising-pathway-for-malignant-treatment